Specifically, they identified lncRNA-urothelial carcinoma associated-1 (lncRNA-UCA1) and WD repeat containing antisense to TP53 (WRAP53) as novel biomarkers for noninvasive diagnosis of HCC [45]. This evidence concerns the gene UCA1 and hepatocellular carcinoma.